tetradecanoylphorbol acetate has been researched along with nitrosocimetidine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, LM; Enomoto, T; Giner-Sorolla, A; Kovatch, RM; Perantoni, AO; Reed, CD; Rice, JM; Riggs, CW | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and nitrosocimetidine
| Article | Year |
|---|---|
N-nitrosocimetidine as an initiator of murine skin tumors with associated H-ras oncogene activation.
Topics: Animals; Carcinogens; Cimetidine; Cocarcinogenesis; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genes, ras; Mice; Mutation; Skin Neoplasms; Survival Analysis; Tetradecanoylphorbol Acetate | 1989 |